199 related articles for article (PubMed ID: 20362237)
1. The scope of mycoplasma contamination within the biopharmaceutical industry.
Armstrong SE; Mariano JA; Lundin DJ
Biologicals; 2010 Mar; 38(2):211-3. PubMed ID: 20362237
[TBL] [Abstract][Full Text] [Related]
2. Mycoplasma testing of cell substrates and biologics: Review of alternative non-microbiological techniques.
Volokhov DV; Graham LJ; Brorson KA; Chizhikov VE
Mol Cell Probes; 2011; 25(2-3):69-77. PubMed ID: 21232597
[TBL] [Abstract][Full Text] [Related]
3. Cross comparison of rapid mycoplasma detection platforms.
Lawrence B; Bashiri H; Dehghani H
Biologicals; 2010 Mar; 38(2):218-23. PubMed ID: 20153218
[TBL] [Abstract][Full Text] [Related]
4. The growth and long term survival of Acholeplasma laidlawii in media products used in biopharmaceutical manufacturing.
Windsor HM; Windsor GD; Noordergraaf JH
Biologicals; 2010 Mar; 38(2):204-10. PubMed ID: 20153666
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
Knezevic I; Stacey G; Petricciani J; Sheets R;
Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods used for detection of mycoplasma contamination in cell cultures, sera, and live-virus vaccines.
Benisheva T; Sovová V; Ivanov I; Opalchenova G
Folia Biol (Praha); 1993; 39(5):270-6. PubMed ID: 8206173
[TBL] [Abstract][Full Text] [Related]
7. Operator-induced contamination in cell culture systems.
Hay RJ
Dev Biol Stand; 1991; 75():193-204. PubMed ID: 1794620
[TBL] [Abstract][Full Text] [Related]
8. Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins.
Eldering JA; Felten C; Veilleux CA; Potts BJ
Biologicals; 2004 Dec; 32(4):183-93. PubMed ID: 15572100
[TBL] [Abstract][Full Text] [Related]
9. Validation of a NAT-based Mycoplasma assay according European Pharmacopoiea.
Deutschmann SM; Kavermann H; Knack Y
Biologicals; 2010 Mar; 38(2):238-48. PubMed ID: 20207553
[TBL] [Abstract][Full Text] [Related]
10. Introduction to papers on mycoplasmology presented at a Parenteral Drug Association mycoplasma workshop.
Potts BJ
Biologicals; 2010 Mar; 38(2):181-2. PubMed ID: 20079662
[No Abstract] [Full Text] [Related]
11. Validation of a PCR method for the detection of mycoplasmas according to European Pharmacopoeia section 2.6.7.
Zhi Y; Mayhew A; Seng N; Takle GB
Biologicals; 2010 Mar; 38(2):232-7. PubMed ID: 20149967
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of mycoplasma in continuous cell lines using a selective biochemical test.
Mariotti E; Mirabelli P; Di Noto R; Fortunato G; Salvatore F
Leuk Res; 2008 Feb; 32(2):323-6. PubMed ID: 17586045
[TBL] [Abstract][Full Text] [Related]
13. [Problems in detection of mycoplasma contamination in cell cultures (author's transl)].
Bonissol C; Gilbert M; Ivanova LM
Ann Microbiol (Paris); 1978; 129B(2):245-65. PubMed ID: 82418
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with the demonstration of Mycoplasma in cell cultures].
Nicklas W; Mauter P
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):510-8. PubMed ID: 3381598
[TBL] [Abstract][Full Text] [Related]
15. Detection of mycoplasma contaminations in cell cultures by PCR analysis.
Uphoff CC; Drexler HG
Hum Cell; 1999 Dec; 12(4):229-36. PubMed ID: 10834110
[TBL] [Abstract][Full Text] [Related]
16. Introduction of a validation concept for a PCR-based Mycoplasma detection assay.
Bruchmüller I; Pirkl E; Herrmann R; Stoermer M; Eichler H; Klüter H; Bugert P
Cytotherapy; 2006; 8(1):62-9. PubMed ID: 16627346
[TBL] [Abstract][Full Text] [Related]
17. Detection of mollicute contamination in cell cultures by 16S rDNA amplification.
Teyssou R; Poutiers F; Saillard C; Grau O; Laigret F; Bové JM; Bébéar C
Mol Cell Probes; 1993 Jun; 7(3):209-16. PubMed ID: 8366866
[TBL] [Abstract][Full Text] [Related]
18. Specifications from a biotechnology industry perspective.
Garnick RL
Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
[TBL] [Abstract][Full Text] [Related]
19. [Mycoplasma contamination of cell cultures: methods for its detection and the possible routes of Mycoplasma infection spread].
Smirnova TD; Fridlianskaia II
Tsitologiia; 1985 Mar; 27(3):276-81. PubMed ID: 2581343
[TBL] [Abstract][Full Text] [Related]
20. An overview of quantitative PCR assays for biologicals: quality and safety evaluation.
Xu Y; Brorson K
Dev Biol (Basel); 2003; 113():89-98. PubMed ID: 14620857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
